The effect of cardiovascular drugs on erectile function: Literature review

作者
Kirill P. Raevskii,Olga Yu. Nesterova,Armais Albertovich Kamalov,Yа. A. Orlova
出处
期刊:Медицинский совет [REMEDIUM GROUP LLC]
卷期号: (7): 238-246
标识
DOI:10.21518/ms2026-018
摘要

Erectile dysfunction (ED) is a common problem among the male population over 40 years old. Arterial hypertension, dyslipidemia and other cardiovascular diseases (CVDs), as well as some of the medications which are used to treat CVDs can affect erectile function (EF). This article discusses current data about cardiovascular drugs effect on EF and analyzes scientific literature from the following scientific databases: PubMed, ScienceDirect, and eLIBRARY.RU. Angiotensin II receptor blockers have a positive effect on EF. ED, as one of the possible side effects, can be observed during treatment by most beta-blockers (with the exception of nebivolol), diuretics, and non-selective mineralocorticoid receptor antagonists. There is no convincing evidence of a negative effect of angiotensin-converting enzyme inhibitors, calcium channel blockers, selective mineralocorticoid receptor antagonists, and metoprolol on EF. The data of the effect of statin therapy on EF is contradictory. There is a limited number of studies about interaction between angiotensin receptors, neprilysin inhibitors and EF. In many studies subjective methods of EF assessment are used. CVDs and ED have common risk factors and pathogenic mechanisms. Large-scale biobank studies using Mendelian randomization show that ED is more strongly associated with the presence of CVDs rather than with the medications. To clarify CVD drugs effects on EF it is necessary to conduct studies with objective assessment of EF using nighttime penile tumescence monitoring. Knowledge of the characteristics of CVD drugs allows doctors to provide patient with an individualized therapy without adverse events, and ensures a high level of patient adherence to treatment.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
邵大王完成签到,获得积分10
刚刚
guoguo发布了新的文献求助10
刚刚
贾亚朋完成签到,获得积分10
刚刚
刚刚
西西完成签到,获得积分10
刚刚
所所的应助被活力的书易采纳,获得10
刚刚
小瞬完成签到,获得积分10
刚刚
百尺竿头完成签到,获得积分10
1秒前
白白不是球完成签到,获得积分10
1秒前
朱良宇完成签到,获得积分10
1秒前
SHX完成签到,获得积分10
1秒前
小二郎的应助被科研通管家采纳,获得10
1秒前
1秒前
1秒前
脑洞疼的应助被科研通管家采纳,获得10
1秒前
在水一方的应助被科研通管家采纳,获得10
1秒前
。。完成签到,获得积分10
2秒前
田様的应助被科研通管家采纳,获得10
2秒前
秋然可可完成签到,获得积分10
2秒前
传奇3的应助被科研通管家采纳,获得10
2秒前
hao123完成签到,获得积分10
2秒前
华仔的应助被科研通管家采纳,获得10
2秒前
2秒前
英姑的应助被科研通管家采纳,获得10
2秒前
喜悦的聪展完成签到 ,获得积分10
2秒前
Jasper的应助被科研通管家采纳,获得10
2秒前
科研通AI2S的应助被科研通管家采纳,获得10
2秒前
刘培恒完成签到,获得积分10
2秒前
乐乐的应助被科研通管家采纳,获得10
3秒前
完美世界的应助被科研通管家采纳,获得10
3秒前
风清扬的应助被科研通管家采纳,获得10
3秒前
Lucas的应助被嘟嘟嘟采纳,获得10
3秒前
SciGPT的应助被科研通管家采纳,获得10
3秒前
刘渝发布了新的文献求助10
3秒前
Lucas的应助被科研通管家采纳,获得10
3秒前
nuomici完成签到,获得积分10
3秒前
Orange的应助被靓靓鱼采纳,获得10
3秒前
twebery完成签到,获得积分10
4秒前
4秒前
RRRZZ完成签到,获得积分10
4秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180339
求助须知:如何正确求助?哪些是违规求助? 9570391
关于积分的说明 21811279
捐赠科研通 7776418
什么是DOI,文献DOI怎么找? 3433277
关于科研通互助平台的介绍 2557483
邀请新用户注册赠送积分活动 2479091